The COVID-19 Clinical Task Force addressed a change in the distribution of monoclonal antibodies, which may impact supply. Current stock should be used judiciously to reach those most at risk for severe disease or hospitalization.
This message is intended for UTMB employees and students, who must be logged onto the UTMB network to access it. Thank you. Please click to read more.